C4 Therapeutics (CCCC) Net Income Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 4.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53% |
| Dec 31, 2025 | 41.10% |
| Sep 30, 2025 | -30.41% |
| Jun 30, 2025 | -46.87% |
| Mar 31, 2025 | 7.19% |
| Dec 31, 2024 | 0.53% |
| Sep 30, 2024 | 8.77% |
| Jun 30, 2024 | 50.68% |
| Mar 31, 2024 | 18.46% |
| Dec 31, 2023 | 6.53% |
| Sep 30, 2023 | 15.40% |
| Jun 30, 2023 | -33.65% |
| Mar 31, 2023 | -9.99% |
| Dec 31, 2022 | -137.48% |
| Sep 30, 2022 | -29.47% |
| Jun 30, 2022 | -19.03% |
| Mar 31, 2022 | -50.78% |
| Dec 31, 2021 | 28.16% |
| Sep 30, 2021 | -13.04% |
| Jun 30, 2021 | -109.21% |
| Mar 31, 2021 | -76.05% |
| Dec 31, 2020 | -117.45% |
| Sep 30, 2020 | -116.32% |